Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Lacombe

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Bone|April 20, 2020
Interaction of sexual dimorphism and gene dosage imbalance in skeletal deficits associated with Down syndromeJared R Thomas, Jonathan LaCombe, Rachel Long, et al.
The Journal of Allergy and Clinical Immunology|April 16, 2021
Rituximab-induced hypogammaglobulinemia and infection risk in pediatric patientsRoxane Labrosse, Sara Barmettler, Beata Derfalvi, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|June 2, 2020
Correction to: Protocol for a double-blind, randomized controlled trial on the dose-related efficacy of omalizumab in multi-food oral immunotherapyAlexandra Langlois, Marie-Hélène Lavergne, Hélène Leroux, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Bone|April 20, 2020
Interaction of sexual dimorphism and gene dosage imbalance in skeletal deficits associated with Down syndromeJared R Thomas, Jonathan LaCombe, Rachel Long, et al.
The Journal of Allergy and Clinical Immunology|April 16, 2021
Rituximab-induced hypogammaglobulinemia and infection risk in pediatric patientsRoxane Labrosse, Sara Barmettler, Beata Derfalvi, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|June 2, 2020
Correction to: Protocol for a double-blind, randomized controlled trial on the dose-related efficacy of omalizumab in multi-food oral immunotherapyAlexandra Langlois, Marie-Hélène Lavergne, Hélène Leroux, et al.
Pageof 3